Your email has been successfully added to our mailing list.

×
0 0 0.0280830280830279 0.0280830280830279 0.0378510378510377 0.0378510378510377 0.0365079365079364 0.0402930402930403
Stock impact report

Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program [Yahoo! Finance]

Delcath Systems, Inc. (DCTH) 
US:NASDAQ Investor Relations: delcath.com/investors
Company Research Source: Yahoo! Finance
QUEENSBURY, N.Y., November 20, 2025 BUSINESS WIRE )--Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath") an interventional oncology company focused on the treatment of primary and metastatic cancers to the liver, today announced that its Board of Directors has authorized a share repurchase program under which Delcath may repurchase up to $25 million of its outstanding shares of common stock from time to time, subject to market conditions. The repurchase program does not have an expiration date. Show less Read more
Impact Snapshot
Event Time:
DCTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
DCTH alerts

from News Quantified
Opt-in for
DCTH alerts

from News Quantified